Microscopic colitis associated with exposure to lansoprazole.
Hilmer
Sarah N
SN
Royal North Shore Hospital, Pacific Highway, St Leonards, NSW 2065, Australia. shilmer@med.usyd.edu.au
Heap
Timothy R
TR
Eckstein
Robert P
RP
Lauer
Christopher S
CS
Shenfield
Gillian M
GM
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000368:Aged; D001706:Biopsy; D002908:Chronic Disease; D046729:Colitis, Collagenous / Q000139:chemically induced / Q000150:complications / Q000473:pathology; D046730:Colitis, Lymphocytic / Q000139:chemically induced / Q000150:complications / Q000473:pathology; D046728:Colitis, Microscopic / Q000139:chemically induced* / Q000150:complications; D003106:Colon / Q000473:pathology; D003967:Diarrhea / Q000139:chemically induced; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D064747:Lansoprazole; D008875:Middle Aged; D009853:Omeprazole / Q000009:adverse effects / Q000031:analogs & derivatives*; D054328:Proton Pump Inhibitors; D013997:Time Factors
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D054328:Proton Pump Inhibitors; D064747:Lansoprazole; D009853:Omeprazole